Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 32, Status: Authorised
What we publish on medicines and when
Vaccines: concerns, questions and false claims
Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 63, Status: Authorised
Performance enhancers - Scientific guideline
Product Management Service (PMS) – Frequently Asked Questions (FAQs)
3Rs Working Party (3RsWP) stakeholder meeting - Public session on the 2026-2028 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 31 March 2026, 09:30 (CEST) to 31 March 2026, 10:30 (CEST)
Opinions and letters of support on the qualification of novel methodologies for medicine development
Annex 4 - Big MS Data (BMSD) feasibility study
Annex 1 - Qualification opinion briefing book for the Big MS Data network registries on Post Authorization Safety Studies